Investors didn't show much interest in one Abcellera Biologics Common Shares way or another today. It hasn't moved too much today but is slightly down, it lost -0.71% since yesterday.
Currently ABCL isn't at a clear support/resistance line that seems tradable. Abcellera Biologics Common Shares has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. ABCL might find some support at the 4.82 level, buyers might push the price back up from here. But it's not very clear what will happen.